The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat

Kenneth S. Kilgore, Karen L. Powers, Michelle M. Imlay, Anu Malani, Douglas I. Allen, Jennifer T. Beyer, Mark B. Anderson, Jeffrey S. Warren

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    We examined the protective effects of GM2941, a sulfated glycomimetic of the complex carbohydrate sialyl Lewis(x), in a model of pulmonary granuloma development. This study was based on the rationale that formation of glucan- induced lung granulomas is dependent on neutrophils and that sialyl Lewis(x) glycomimetic (GM2941)interferes, in vitro, with P-selectin-dependent neutrophil-endothelial adhesive interactions. Infusion of particulate yeast cell wall glucan into rats results in the rapid (48 hr) formation of monocyte/macrophage-rich angiocentric pulmonary granulomas. Development of granulomas exhibits a temporal pattern characterized by the early, transient influx of neutrophils into blood vessel walls at sites of glucan embolization, followed by accumulation of monocytes and macrophages that constitute the definitive angiocentric lesions. Within 1 hr after the infusion of glucan, immunohistochemical analysis revealed up-regulation of blood vessel wall-associated P-selectin. Previous studies utilizing neutrophil-depleted animals have revealed that neutrophils, although not present in definitive lesions, are required for full granuloma development. The potential of GM2941 to inhibit neutrophil-endothelial cell adhesive interactions was demonstrated by the ability of the compound to inhibit P- selectin-mediated adhesion to histamine-stimulated HUVECs. Infusion of GM2941 retarded pulmonary granuloma development in a dose-dependent manner. Whole- lung myeloperoxidase activity, measured at the time of peak neutrophil accumulation, was significantly reduced in animals pretreated with GM2941 (30 mg/kg, 24 μM/kg), which suggests that this compound affords protection, at least in part, through impedance of neutrophil recruitment. These data indicate that GM2941 affords a significant degree of protection against granuloma formation associated with glucan infusion, probably through the interruption of neutrophil recruitment.

    Original languageEnglish (US)
    Pages (from-to)439-446
    Number of pages8
    JournalJournal of Pharmacology and Experimental Therapeutics
    Volume286
    Issue number1
    StatePublished - Jul 1998

    Fingerprint

    Glucans
    Vasculitis
    Granuloma
    Neutrophils
    Carbohydrates
    Lung
    P-Selectin
    Neutrophil Infiltration
    Adhesives
    Blood Vessels
    Monocytes
    Macrophages
    5-acetylneuraminyl-(2-3)-galactosyl-(1-4)-(fucopyranosyl-(1-3))-N-acetylglucosamine
    Electric Impedance
    Cell Communication
    Cell Wall
    Histamine
    Peroxidase
    Up-Regulation
    Endothelial Cells

    ASJC Scopus subject areas

    • Pharmacology

    Cite this

    Kilgore, K. S., Powers, K. L., Imlay, M. M., Malani, A., Allen, D. I., Beyer, J. T., ... Warren, J. S. (1998). The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat. Journal of Pharmacology and Experimental Therapeutics, 286(1), 439-446.

    The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat. / Kilgore, Kenneth S.; Powers, Karen L.; Imlay, Michelle M.; Malani, Anu; Allen, Douglas I.; Beyer, Jennifer T.; Anderson, Mark B.; Warren, Jeffrey S.

    In: Journal of Pharmacology and Experimental Therapeutics, Vol. 286, No. 1, 07.1998, p. 439-446.

    Research output: Contribution to journalArticle

    Kilgore, KS, Powers, KL, Imlay, MM, Malani, A, Allen, DI, Beyer, JT, Anderson, MB & Warren, JS 1998, 'The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat', Journal of Pharmacology and Experimental Therapeutics, vol. 286, no. 1, pp. 439-446.
    Kilgore, Kenneth S. ; Powers, Karen L. ; Imlay, Michelle M. ; Malani, Anu ; Allen, Douglas I. ; Beyer, Jennifer T. ; Anderson, Mark B. ; Warren, Jeffrey S. / The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat. In: Journal of Pharmacology and Experimental Therapeutics. 1998 ; Vol. 286, No. 1. pp. 439-446.
    @article{e2a604cec9eb4b3f9ff0928e30de469e,
    title = "The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat",
    abstract = "We examined the protective effects of GM2941, a sulfated glycomimetic of the complex carbohydrate sialyl Lewis(x), in a model of pulmonary granuloma development. This study was based on the rationale that formation of glucan- induced lung granulomas is dependent on neutrophils and that sialyl Lewis(x) glycomimetic (GM2941)interferes, in vitro, with P-selectin-dependent neutrophil-endothelial adhesive interactions. Infusion of particulate yeast cell wall glucan into rats results in the rapid (48 hr) formation of monocyte/macrophage-rich angiocentric pulmonary granulomas. Development of granulomas exhibits a temporal pattern characterized by the early, transient influx of neutrophils into blood vessel walls at sites of glucan embolization, followed by accumulation of monocytes and macrophages that constitute the definitive angiocentric lesions. Within 1 hr after the infusion of glucan, immunohistochemical analysis revealed up-regulation of blood vessel wall-associated P-selectin. Previous studies utilizing neutrophil-depleted animals have revealed that neutrophils, although not present in definitive lesions, are required for full granuloma development. The potential of GM2941 to inhibit neutrophil-endothelial cell adhesive interactions was demonstrated by the ability of the compound to inhibit P- selectin-mediated adhesion to histamine-stimulated HUVECs. Infusion of GM2941 retarded pulmonary granuloma development in a dose-dependent manner. Whole- lung myeloperoxidase activity, measured at the time of peak neutrophil accumulation, was significantly reduced in animals pretreated with GM2941 (30 mg/kg, 24 μM/kg), which suggests that this compound affords protection, at least in part, through impedance of neutrophil recruitment. These data indicate that GM2941 affords a significant degree of protection against granuloma formation associated with glucan infusion, probably through the interruption of neutrophil recruitment.",
    author = "Kilgore, {Kenneth S.} and Powers, {Karen L.} and Imlay, {Michelle M.} and Anu Malani and Allen, {Douglas I.} and Beyer, {Jennifer T.} and Anderson, {Mark B.} and Warren, {Jeffrey S.}",
    year = "1998",
    month = "7",
    language = "English (US)",
    volume = "286",
    pages = "439--446",
    journal = "Journal of Pharmacology and Experimental Therapeutics",
    issn = "0022-3565",
    publisher = "American Society for Pharmacology and Experimental Therapeutics",
    number = "1",

    }

    TY - JOUR

    T1 - The carbohydrate sialyl Lewis(x) (sLe(x)) sulfated glycomimetic GM2941 attenuates glucan-induced pulmonary granulomatous vasculitis in the rat

    AU - Kilgore, Kenneth S.

    AU - Powers, Karen L.

    AU - Imlay, Michelle M.

    AU - Malani, Anu

    AU - Allen, Douglas I.

    AU - Beyer, Jennifer T.

    AU - Anderson, Mark B.

    AU - Warren, Jeffrey S.

    PY - 1998/7

    Y1 - 1998/7

    N2 - We examined the protective effects of GM2941, a sulfated glycomimetic of the complex carbohydrate sialyl Lewis(x), in a model of pulmonary granuloma development. This study was based on the rationale that formation of glucan- induced lung granulomas is dependent on neutrophils and that sialyl Lewis(x) glycomimetic (GM2941)interferes, in vitro, with P-selectin-dependent neutrophil-endothelial adhesive interactions. Infusion of particulate yeast cell wall glucan into rats results in the rapid (48 hr) formation of monocyte/macrophage-rich angiocentric pulmonary granulomas. Development of granulomas exhibits a temporal pattern characterized by the early, transient influx of neutrophils into blood vessel walls at sites of glucan embolization, followed by accumulation of monocytes and macrophages that constitute the definitive angiocentric lesions. Within 1 hr after the infusion of glucan, immunohistochemical analysis revealed up-regulation of blood vessel wall-associated P-selectin. Previous studies utilizing neutrophil-depleted animals have revealed that neutrophils, although not present in definitive lesions, are required for full granuloma development. The potential of GM2941 to inhibit neutrophil-endothelial cell adhesive interactions was demonstrated by the ability of the compound to inhibit P- selectin-mediated adhesion to histamine-stimulated HUVECs. Infusion of GM2941 retarded pulmonary granuloma development in a dose-dependent manner. Whole- lung myeloperoxidase activity, measured at the time of peak neutrophil accumulation, was significantly reduced in animals pretreated with GM2941 (30 mg/kg, 24 μM/kg), which suggests that this compound affords protection, at least in part, through impedance of neutrophil recruitment. These data indicate that GM2941 affords a significant degree of protection against granuloma formation associated with glucan infusion, probably through the interruption of neutrophil recruitment.

    AB - We examined the protective effects of GM2941, a sulfated glycomimetic of the complex carbohydrate sialyl Lewis(x), in a model of pulmonary granuloma development. This study was based on the rationale that formation of glucan- induced lung granulomas is dependent on neutrophils and that sialyl Lewis(x) glycomimetic (GM2941)interferes, in vitro, with P-selectin-dependent neutrophil-endothelial adhesive interactions. Infusion of particulate yeast cell wall glucan into rats results in the rapid (48 hr) formation of monocyte/macrophage-rich angiocentric pulmonary granulomas. Development of granulomas exhibits a temporal pattern characterized by the early, transient influx of neutrophils into blood vessel walls at sites of glucan embolization, followed by accumulation of monocytes and macrophages that constitute the definitive angiocentric lesions. Within 1 hr after the infusion of glucan, immunohistochemical analysis revealed up-regulation of blood vessel wall-associated P-selectin. Previous studies utilizing neutrophil-depleted animals have revealed that neutrophils, although not present in definitive lesions, are required for full granuloma development. The potential of GM2941 to inhibit neutrophil-endothelial cell adhesive interactions was demonstrated by the ability of the compound to inhibit P- selectin-mediated adhesion to histamine-stimulated HUVECs. Infusion of GM2941 retarded pulmonary granuloma development in a dose-dependent manner. Whole- lung myeloperoxidase activity, measured at the time of peak neutrophil accumulation, was significantly reduced in animals pretreated with GM2941 (30 mg/kg, 24 μM/kg), which suggests that this compound affords protection, at least in part, through impedance of neutrophil recruitment. These data indicate that GM2941 affords a significant degree of protection against granuloma formation associated with glucan infusion, probably through the interruption of neutrophil recruitment.

    UR - http://www.scopus.com/inward/record.url?scp=0031821565&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0031821565&partnerID=8YFLogxK

    M3 - Article

    VL - 286

    SP - 439

    EP - 446

    JO - Journal of Pharmacology and Experimental Therapeutics

    JF - Journal of Pharmacology and Experimental Therapeutics

    SN - 0022-3565

    IS - 1

    ER -